We're so glad you're here! This site is to help anyone diagnosed with Medullary Thyroid Cancer and their caregivers find valuable information and support. If you'd like to connect with others with MTC, please consider joining our very active Facebook Group. You don't have to go through this alone!
If you don't yet have a copy, please download the American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma, aka "The Guidelines." This is the MTC Bible. Read it and know it and it will help you and your doctor ensure you get the proper treatment.
Lastly, please consider looking into being seen by an MTC expert. We do our best to keep a running list of what we call "Centers of Excellence." These are doctors and facilities that are properly trained and experienced enough to treat MTC patients. It's one of the most important decisions you can make on your journey.
"Selpercatinib is a highly selective and potent RET inhibitor that was approved for the treatment of patients with advanced or metastatic medullary ..."
"... medullary thyroid cancer (Abstract 4208O). Additionally, primary results from a phase II trial demonstrated safety and antitumor activity for ..."
"The medications are generally contraindicated for patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine ..."
"... GAVRETO achieved an overall response rate (ORR) of 53% in patients with RET fusion-positive solid tumors, excluding NSCLC and thyroid cancer, with ..."
"It remains unknown whether those findings translate into an increased risk of medullary thyroid carcinoma in humans. The medications are generally ..."
This website is intended for educational purposes only. It is not intended, nor should it be interpreted, as medical advice or instructions of any kind. Readers are advised to consult their own medical doctor(s) for all matters involving their health and medical care.